Lateral Flow Manufacturing Trouble Shooting Guide - Abingdon Health plcChina invents rapid test kit for potential severe COVID-19 casesRapid Test Kits - Creative DiagnosticsNot known Details About Tech transfer deals to lower costs of COVID-19 rapid testsOthers are less sensitive however still useful. Some perform badly enough that they should not be used. Where possible, we suggest reading independent recognition reports, such as the FIND report, and not simply counting on producer claims. [Last updated March 4, 2021]NPR's Adrian Florido consults with Estela Raychaudhuri, president of In, Bios International, about difficulties dealt with by coronavirus rapid test kit makers amidst the current rise. ADRIAN FLORIDO, HOST: The most popular product of the new year may extremely well be COVID-19 at-home quick tests. Amid the current surge of infections, need for the tests has actually skyrocketed.Provided the fast spread of the omicron version, the tests have actually become an important tool for individuals who desire to rapidly discover out if they've been infected. And last month, the Biden administration revealed its strategy to disperse 500 million quick tests to Americans who request them. That and the more comprehensive demand from consumers has test manufacturers hurrying to ramp up production.Estella Raychaudhuri is president of In, Bios International, based in Seattle. Estella Raychaudhuri, thanks for joining us today. ESTELLA RAYCHAUDHURI: Thank you for having me. FLORIDO: Your business has actually invested the last few weeks trying to increase production of these rapid tests. The number of tests were you producing before demand began to surge, and what are your targets now? RAYCHAUDHURI: Well, we only just recently received emergency situation use permission for our tests from the FDA.Not known Incorrect Statements About COVID test makers set to make $4 billion in U.SgovernmentTherefore we have been ramping up to get all of our products in location, our printed materials in location. Read This are 2 million tests each week. And after that we desire to scale up really rapidly to 5 to 10 million in the next month approximately. FLORIDO: And what have you done to try to make sure that you arrive? RAYCHAUDHURI: Well, we have actually been hiring a lot.So these are simply a few of the steps that we are requiring to guarantee that we're able to increase and fulfill the demand. FLORIDO: We've become aware of the supply chain problems that have actually been pestering our nation for months now. Are they affecting the reach of these goals? RAYCHAUDHURI: Yes, they are.
